Sg3 Management, LLC Pfizer Inc Call Options Transaction History

Sg3 Management, LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $34.5 Million - $43.8 Million	-1,029,900 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $31.1 Million - $36.5 Million	980,500 Added 1984.82%	1,029,900 $37.8 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $1.49 Million - $1.81 Million	49,400 New	49,400 $1.62 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $380,133 - $492,921	-11,700 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$36.98 - $41.52 $432,665 - $485,784	11,700 New	11,700 $507,000
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $300,000 - $329,600	-8,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $307,760 - $350,880	8,000 New	8,000 $349,000
Q3 2017 Jan 25, 2018	SELL	$31.0 - $34.15 $930,000 - $1.02 Million	-30,000 Closed	0 $0
Q2 2017 Feb 26, 2018	BUY	N/A	29,700 Added 9900.0%	30,000 $1.01 Million
Q2 2017 Jan 25, 2018	BUY	N/A	300 New	300 $33,000
Q1 2017 Jan 25, 2018	SELL	N/A	-15,000 Closed	0 $0
Q4 2016 Feb 23, 2018	BUY	N/A	14,850 Added 9900.0%	15,000 $487,000
Q4 2016 Jan 24, 2018	BUY	N/A	150	150 $21,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.